Chronic obstructive pulmonary disease: A slowly progressive cardiovascular disease masked by its pulmonary effects?

European Journal of Heart Failure

Volumn 14, Issue 4, 2012, Pages 348-350

  Rutten, Frans H ^a   Hoes, Arno W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BISOPROLOL; CARVEDILOL; METOPROLOL; NEBIVOLOL;

AIRWAY OBSTRUCTION; ATHEROSCLEROSIS; BRONCHOSPASM; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DISEASE ASSOCIATION; DISEASE COURSE; ECHOCARDIOGRAPHY; FORCED EXPIRATORY VOLUME; HEART FAILURE; HUMAN; LUNG FUNCTION; PRIORITY JOURNAL; REVIEW; RISK; SYSTOLIC DYSFUNCTION; THORAX RADIOGRAPHY;

CORONARY ARTERY DISEASE; FEMALE; HEART FAILURE; HEART FAILURE, SYSTOLIC; HOSPITALIZATION; HUMANS; LUNG; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84859027990     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfs022     Document Type: Review

References (22)

1. Kachel R. Left ventricular function in chronic obstructive pulmonary disease. Chest 1978;74:286-290.
2. Rutten FH, Cramer MJM, Lammers JWJ, Grobbee DE, Hoes AW. Heart failure and chronic obstructive pulmonary disease: an ignored combination? Eur J Heart Fail 2006;8:706-711.
3. McCullough PA, Hollander JE, Nowak RM, Storrow AB, Duc P, Omland T, McCord J, Herrmann HC, Steg PG, Westheim A, Knudsen CW, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS; BNP Multinational Study Investigators. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med 2003;10:198-204.
4. Rutten FH, Cramer MJM, Grobbee DE, Sachs APE, Kirkels JH, Lammers JWJ, Hoes AW. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005;26:1887-1894.
5. Naeije R. Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:20-22.
6. Vonk Noordegraaf A, Marcus JT, Roseboom B, Postmus PE, Faes TJ, de Vries PM. The effect of right ventricular hypertrophy on left ventricular ejection fraction in pulmonary emphysema. Chest 1997;112:640-645.
7. Agarwal SK, Heiss G, Barr RG, Chang PP, Loehr LR, Chambless LE, Shahar E, Kitzman DW, Rosamond WD. Airflow obstruction, lung function, and risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study. Eur J Heart Fail 2012;14:414-422.
8. Mentz RJ, Fiuzat M, Wojdyla DM, Chiswell K, Gheorghiade M, Fonarow GC, O'Connor CM. Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF. Eur J Heart Fail 2012;14:395-403.
9. Engstrom G, Melander O, Hedblad B. Population-based study of lung function and incidence of heart failure hospitalizations. Thorax 2010;65:633-638.
10. Rutten FH, Moons KCM, Cramer MJM, Grobbee DE, Zuithoff NPA, Lammers JWJ, Hoes AW. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 2005;331:1379.
11. Boudestein LC, Rutten FH, Cramer MJ, Lammers JW, Hoes AW. The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease. Eur J Heart Fail 2009;11:1182-1188.
12. Rusinaru D, Saadi I, Godard S, Mahjoub H, Battle C, Tribouilloy C. Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure. Am J Cardiol 2008;101:353-358.
13. Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C, Vestbo J, Kjoller E, and ECHOS Lung Function Study Group. The prognostic importance of lung function in patients admitted with heart failure. Eur J Heart Fail 2010;12:685-691.
14. Kwon BJ, Kim DB, Jang SW, Yoo KD, Moon KW, Shim BJ, Ahn SH, Cho EJ, Rho TH, Kim JH. Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease. Eur J Heart Fail 2010;12:1339-1344.
15. Hawkins NM, Petrie MC, Macdonald MR, Jhund PS, Fabbri LM, Wikstrand J, McMurray JJV. Heart failure and chronic obstructive pulmonary disease. The quandary of beta-blockers and beta-agonists. J Am Coll Cardiol 2011;57: 2127-2138.
16. Hawkins NM,Wang D, Petrie MC, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Solomon SD, Ostergren J, Michelson EL, Pocock SJ, Maggioni AP, McMurray JJV, for the CHARM Investigators and Committees. Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme. Eur J Heart Fail 2010;12:557-565.
17. Lin R, Peng H, Nguyen LP, Dudekula NB, Shardonofsky F, Knoll BJ, Parra S, Bond RA. Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model. Pulm Pharmacol Ther 2008;21:115-124.
18. Nguyen LP, Omoluabi O, Parra S, Frieske JM, Clement C, Ammar-Aouchiche Z, Ho SB, Ehre C, Kesimer M, Knoll BJ, Tuvim MJ, Dickey BF, Bond RA. Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model. Am J Respir Cell Mol Biol 2008;38:256-262.
19. Rutten FH, Zuithoff NPA, Hak E, Grobbee DE, Hoes AW. Beta-blockers may reduce mortality and risk of exacerbations of patients with chronic obstructive pulmonary disease. Arch Intern Med 2010;170:880-887.
20. Short PM, Lipworth SI, Elder DH, Schembri S, Lipworth BJ. Effect of beta-blockers in treatment of chronic obstructive pulmonary disease. BMJ 2011;342:d2549.
21. Andreas S, Anker SD, Scanlon PD, Somers VK. Neurohormonal activation as a link to systemic manifestations of chronic obstructive pulmonary disease. Chest 2005;128:3618-3624.
22. Hawkins NM, Jhund PS, Simpson CR, Petrie MC, Macdonald MR, Dunn FG, MacIntyre K, McMurray JJV. Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland. Eur J Heart Fail 2010;12:17-24.